| Non-complicated FN (n = 79) | Septic shock (n = 20) | P |
---|---|---|---|
Gender (male: female) | 44:35 | 12:8 | NS** |
Age (median, range) | 49 (13 to 78) | 52 (21 to 78) | NS** |
Diagnostic NS** | |||
Acute leukemia | 30 | 10 | Â |
Other hematolgical malignancies | 49 | 10 | Â |
Comorbidities (present:absent) | 29:40 | 8:12 | NS** |
Treatment NS** | |||
Intensive CTx/autologus HSCT | 62 | 15 | Â |
Allogeneic HSCT | 17 | 5 | Â |
Neutrophils/µl (median, range) | 80 (0 to 500) | 0 (0 to 500) | NS* |
Platelets x10³/µl (median, range) | 21,000 (4,000 to 215,000) | 14,500 (3,000 to 39,000) | NS* |
Agent isolation in bloodstream*** (yes:no) | 27:52 | 7:13 | NS** |
C reactive protein mg/dl (median, range) | 11.20 (0.55 to 58.30) | 12.7 (6.2 to 40.90) | NS* |
SOFA score (median, range) | 4 (0 to 8) | 4 (2 to 14) | P <0,05* |
MASCC score (median, range) | 19 (12 to 23) | 18 (12 to 21) | NS* |
Time to sample collection hours (median, range) | 48 (3 to 120) | Â | |
Time to septic shock days (median, range) | 3 (1 to 17) | Â |